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atients With Hibernating Myocardium
how Altered Left Ventricular Volumes
nd Shape, Which Revert After Revascularization
vidence That Dyssynergy Might Directly Induce Cardiac Remodeling
rberto Carluccio, MD,* Paolo Biagioli, MD,* Gianfranco Alunni, MD,* Adriano Murrone, MD,*
laudio Giombolini, MD,* Temistocle Ragni, MD,† Paolo N. Marino, MD,§
ianpaolo Reboldi, MD, PHD, MSC,‡ Giuseppe Ambrosio, MD, PHD, FACC*
erugia and Novara, Italy
OBJECTIVES The purpose of this study was to investigate whether post-ischemic left ventricular (LV)
remodeling might be induced by regional contractile dysfunction per se (i.e., in the absence
of transmural necrosis) and whether this phenomenon is potentially reversible after contractile
recovery.
BACKGROUND Formation of extensive scar tissue is thought to be chiefly responsible for post-infarction LV
remodeling; however, myocardial necrosis also causes loss of contractility. We investigated
LV geometry and shape in a setting in which contractile dysfunction occurs in the presence
of preserved myocyte viability, and thus it is potentially reversible.
METHODS In 42 patients with chronically dysfunctional myocardium, we evaluated (by two-dimensional
echocardiography) LV global and regional function, volumes, and sphericity index (SI), at
baseline and 8  3 months after coronary revascularization. Myocardial viability before
revascularization was evaluated by dobutamine echocardiography.
RESULTS At baseline, regional and global function were depressed and LV dilation was present.
Revascularization was followed by recovery of ejection fraction (from 33  6% to 45  10%,
p  0.0001) and wall motion score index (from 2.29  0.31 to 1.74  0.42, p  0.0001).
After revascularization, significant improvement of end-systolic volume index (from 78  23
ml/m2 to 56  23 ml/m2, p  0.0001), end-diastolic volume index (from 118  26 ml/m2
to 99  26 ml/m2, p  0.0001), and SI (from 0.69  0.14 to 0.52  0.11, p  0.0001) was
also observed. Improvement in LV volumes and SI were significantly correlated to the
number of segments recovering function after revascularization.
CONCLUSIONS Hibernating myocardium is associated with major alterations in LV volumes and shape,
which significantly revert after revascularization. Thus, chronic dyssynergy per se is sufficient
to induce ischemic LV remodeling in patients. (J Am Coll Cardiol 2006;47:969–77)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.064© 2006 by the American College of Cardiology Foundation
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mccurrence of large transmural infarction is followed by a
eries of events (collectively referred to as “post-infarction
entricular remodeling”) characterized by replacement of
ecrotic myocardium with scar tissue, increased size of
See page 978
yocytes and interstitial fibrosis in remote areas, and
lteration in shape and dilation of the whole left ventricle
LV). Typically, remodeling develops after large transmural
nfarcts, particularly of the anterior wall (1–5).
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IUR, Rome, Italy. Presented at the 54th Annual Scientific Sessions of the
merican College of Cardiology, Orlando, Florida, March 6–9, 2005.t
Manuscript received March 25, 2005; revised manuscript received September 8,
005, accepted September 19, 2005.Regarding the mechanisms through which myocardial
nfarction might alter LV geometry, emphasis is currently
oncentrated on the structural and inflammatory conse-
uences of the healing process that follows transmural
ecrosis. In the few years since 2000, over 70 studies have
een published dealing with experimental models of post-
schemic LV remodeling secondary to transmural infarction
see the Appendix); within this setting, research almost
xclusively focused on remodeling as influenced either by
car formation/extracellular collagen deposition (e.g.,
hrough metallo-proteinase activity) or by the inflammatory
esponse (for review, see references [6–9]; also see the
ppendix). Those mechanisms, however, are unlikely to
ntirely explain the complex pathophysiology of ischemic
emodeling. Indeed, the only clinical data available do not
upport inhibition of metallo-proteinases as a means of
reventing post-infarction remodeling (10).
Necrosis obviously implies replacement of normal
yocardium with non-contracting tissue. Thus, in addi-ion to the specific process of tissue repair, the infarcted
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Hibernation and Remodeling March 7, 2006:969–77rea is also characterized by lack of contribution to car-
iac contraction. Yet, whether such a “mechanical” factor
ontributes to post-infarction remodeling is largely un-
nown, in part because of the obvious difficulty of
eparating the effects of necrosis on contractility from
hose on scar formation. This would be important to
nderstand, because it is expected that regional dysfunc-
ion might augment LV load and wall stress, which in
urn might trigger remodeling (7,11).
We investigated whether regional contractile dysfunction
er se is sufficient to promote LV remodeling. Toward this
oal, we exploited the peculiar clinical condition of patients
n whom chronic regional contractile dysfunction occurs in
he absence of necrosis, distal to severe coronary artery
tenosis. Furthermore, because this dyssynergic myocardium
etains viability, it is amenable to functional recovery after
evascularization; this would allow an assessment of whether
V remodeling might also revert after regain of contractile
unction, which in turn would offer additional insight
oward establishing a link between chronic dyssynergy and
schemic remodeling.
ETHODS
atient selection. We enrolled consecutive patients sched-
led to undergo elective coronary artery revascularization.
nclusion criteria were: 1) 70% stenosis in at least one
ajor coronary artery at angiography, suitable for surgical or
ercutaneous revascularization; 2) LV dysfunction (ejection
raction 40%); 3) adequate echocardiographic evaluation
f function in all LV segments; and 4) no evidence of
ransmural infarction (i.e., no deep Q waves in inferior leads
nd preserved R waves in anterior leads; absence of hypere-
hogenic, thinned segments at echocardiography; absence of
car upon direct inspection at surgery). Patients were ex-
luded if they had acute coronary syndrome 3 months
receding the study, significant valvular heart disease, left
undle branch block, or previous surgical revascularization.
tudy protocol. After signing the informed consent, LV
lobal and regional function was evaluated by baseline
wo-dimensional echocardiography; viability of dyssynergic
egments was then assessed by contractile response to
obutamine (see “Dobutamine stress echocardiography”
ection to follow). Therapy was maintained, except for
eta-blockers, which were discontinued 48 h before dobut-
mine echocardiography. Patients were then referred to
ndergo revascularization within one month. Follow-up
Abbreviations and Acronyms
EDVI  end-diastolic volume index
ESVI  end-systolic volume index
LV  left ventricle
SI  sphericity index
WMSI  wall motion score indexvaluation, performed 4 months after coronary revascu- barization, included repeat assessment of LV global and
egional function and of LV volumes and shape.
aseline echocardiography. Two-dimensional echocardi-
graphy was performed with a SONOS 4500 machine
Philips Technologies, Andover, Massachusetts), equipped
ith a 2.5-MHz transducer. Patients were studied in left
ateral decubitus, in parasternal short- and long-axis and
pical four- and two-chamber views. The endocardial bor-
er at end-diastole and end-systole was planimetered in-
luding papillary muscles in the blood volume. End-diastole
as defined as the frame with the largest cavity immediately
efore the onset of QRS complex and end-systole as the
rame with the smallest cavity area. The LV volumes and
jection fraction were calculated according to the modified
impson’s rule (12). Three cardiac cycles were averaged for
ach measurement. Volume indexes were obtained dividing
V volumes by body surface area. The LV sphericity index
SI) was calculated as: end-diastolic volume/([long-axis
iameter3  ]/6) (13). Long-axis diameter was measured
n the apical four-chamber view from the distance in
iastole between apical endocardium and mitral annulus;
he higher the SI, the more spherical the left ventricle (13).
eridional and circumferential end-systolic wall stress were
alculated by standard formulas (14,15). Systolic thickening
f septum and posterior wall was calculated from M-mode
racings obtained by two-dimensional images of short-axis
iews at the papillary muscle level. Regional wall motion
as assessed with a 16-segment model of the LV on a
our-point grade scale, according to the American Society of
chocardiography (12). Wall motion score index (WMSI)
as calculated as the sum of the score of each segment
ivided by the number of segments scored. Severity of
itral regurgitation was estimated by the area of color-
oppler flow velocity in the left atrium, as suggested by the
oppler Quantification Task Force Committee of the
merican Society of Echocardiography (16).
Echocardiograms were recorded with a Super-VHS
ideotape recorder or digitally stored on optical disk. Sub-
equent off-line analysis was performed by two investigators
ithout knowledge of clinical and angiographic data. Dis-
greements in interpretation were resolved by consensus.
Reproducibility of LV volume measurements was as-
essed in 15 randomly-chosen baseline echocardiograms. By
land-Altman method (17), mean  SD difference be-
ween two observers for end-diastolic volume was 0.57 
2 ml (r 0.96), and4.3 12 ml for end-systolic volume
r  0.96).
obutamine stress echocardiography. To assess LV con-
ractile reserve, dobutamine was infused intravenously via a
yringe pump at the dose of 5 g/kg/min for 5 min and
ncreased to 10 g/kg/min for an additional 5 min; in case
f no contractile response, an additional 15 g/kg/min were
nfused for further 5 min. Parasternal long-axis and short-
xis and apical four- and two-chamber views were moni-
ored during the study. Electrocardiogram, heart rate, and
lood pressure were recorded at rest, every 2 min during the
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March 7, 2006:969–77 Hibernation and Remodelingest, and up to 10 min after the end of drug infusion.
riteria for stopping dobutamine infusion included hypo-
ension, angina, worsening of wall motion, and significant
entricular arrhythmias. The WMSI was calculated at
aseline and at the end of dobutamine infusion. Improve-
ent of contractile function of 1 grade from baseline in at
east two adjacent dysfunctional segments was considered as
sign of viability. The number of viable segments in
esponse to dobutamine was also considered; viability index
VI) was calculated as the number of viable segments
ivided by the number of total dysfunctional segments at
aseline (18). Intraobserver and interobserver reproducibil-
ty of stress-echo readings in our laboratory is 90% (19).
tatistical analysis. Continuous data are presented as
ean  SD. Categorical variables were compared by
hi-square test; in case of 2  2 tables, when the df  1,
ates correction was applied. Comparison of continuous
ariables at baseline between groups was performed by
npaired t test; Mann-Whitney U test was used for non-
arametric data such as WMSI. Resting and peak values, as
ell as baseline and follow-up data, were compared using
aired t test; Wilcoxon rank sum test was used for non-
arametric data such as WMSI. Comparison between
roups (viability vs. viability) from baseline to follow-up
as performed with analysis of variance for repeated mea-
ures corrected for unbalanced design. Pearson’s correlation
oefficient was used to determine relation between variables.
nivariate and multiple regression analyses were performed
o evaluate the association between clinical and echocardio-
raphic variables and changes in end-diastolic volume index
EDVI), end-systolic volume index (ESVI), and SI at
ollow-up. Inter-observer variability of EDVI and ESVI
as analyzed by linear regression analysis and Bland-
ltman method (17). A p value  0.05 was considered
ignificant. The SPSS statistical package version 10 was
sed for analysis (SPSS Inc., Chicago, Illinois).
ESULTS
atients. Fifty-five patients met the inclusion criteria and
ere enrolled. Two patients subsequently refused to un-
ergo revascularization. After 20  9 days, patients were
eadmitted; echocardiography confirmed the persistence of
V dysfunction; on the subsequent morning, patients were
evascularized by percutaneous transluminal coronary angio-
lasty (n  16), or coronary artery by-pass graft (n  37).
he choice of modality of revascularization was made by the
ttending physicians independent of the study, on the basis
f coronary anatomy and clinical status. There were no
eriprocedural myocardial infarctions. Of 53 revascularized
atients, 3 died before follow-up and 6 were lost at
ollow-up. Two patients were excluded because of acute
oronary syndrome before follow-up. Thus, 42 patients
onstitute the final population. Baseline clinical, demo-
raphic, and echocardiographic features of study patients are 0ummarized in Table 1 and presented for each patient as in
he Appendix.
aseline echocardiography. At baseline, all patients showed
nlarged LV and depressed global function (Table 2).
xtensive regional contractile dysfunction was also present.
f a total 516 dysfunctional segments, 182 were hypoki-
etic and 323 akinetic. Only 11 segments were dyskinetic
nd always localized in the inferior region.
Low-dose dobutamine echocardiography unmasked sub-
tantial contractile reserve in an average of 6  3 segments
er patient. The WMSI averaged 2.29  0.31 at baseline,
nd it largely improved to 1.79  0.32 (p  0.0001) at the
nd of dobutamine infusion, with a mean viability index of
.49  0.21.
evascularization and LV function and volumes. Pa-
ients were reevaluated 7.6  3.3 months after revascular-
zation. Revascularization significantly improved global and
egional LV function (Table 2). In the whole population,
jection fraction increased from 33 6% to 45 10% (p
.0001) and WMSI from 2.29  0.31 to 1.74  0.42 (p 
.0001). Of the 6  3 segments per patient identified as
iable at baseline, 88  32% exhibited substantial recovery
f function at follow-up, with an average 5  3 segments
er patient showing1 grade of improvement. The number
f segments that recovered function at follow-up was
ignificantly related to the number of viable segments
dentified by dobutamine echocardiography at baseline (r 
.68, p  0.0001) and to viability index (r  0.65, p 
able 1. Patient Population
ge (yrs) 65  9
ales (%) 35 (83)
ody surface area (m2) 1.88  0.17
ystolic blood pressure (mm Hg) 128  15
iastolic blood pressure (mm Hg) 78  10
eart rate (beats/min) 71  12
YHA functional class 3.1  0.8
isk factors
Hypertension (%)* 25 (60)
Diabetes (%)† 16 (38)
Hypercholesterolemia (%)‡ 27 (64)
Smokers (%) 8 (19)
History of non–Q-wave MI (%) 22 (52)
oronary anatomy
1-vessel disease (%) 6 (14)
2-vessel disease (%) 12 (29)
3-vessel disease (%) 24 (57)
Mean coronary stenosis (%)§ 86.7  11
edications
Nitrates (%) 34 (81)
ACE inhibitors (%) 38 (91)
Beta-blockers (%) 21 (50)
Diuretics (%) 26 (62)
Aspirin (%) 39 (93)
Calcium-channel blockers (%) 7 (17)
On therapy, or resting blood pressure 140/90 mm Hg; †on therapy, or fasting
lood sugar 127 mg/dl; ‡on therapy, or total cholesterol 220 mg/dl; §mean
oronary stenosis of the artery supplying dysfunctional but viable myocardium.
ACE  angiotensin-converting enzyme; MI  myocardial infarction; NYHA 
ew York Heart Association..0001).
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Hibernation and Remodeling March 7, 2006:969–77In addition to wall motion analysis, regional contractile
unction was also directly assessed by measuring systolic
hickening of dysfunctional and remote regions. Systolic
hickening of interventricular septum was depressed at
aseline, compared with that of the posterior wall (23 
0% vs. 43  23%, p  0.01). At follow-up, systolic
hickening of the interventricular septum significantly in-
reased to 33  23% (p  0.01); thickening of the posterior
all also showed an increase (to 49  21%), which did not
each statistical significance.
Improvement of function after revascularization was also
ccompanied by major improvement of LV volumes and
eometry, as shown by significant reduction of ESVI (p 
.0001), EDVI (p  0.0001), and SI (p  0.0001) (Table
). Figure 1 shows the changes in ESVI, EDVI, and SI,
rom baseline to follow-up in each patient. A reduction of
SVI was observed in all but 5 patients, and in 29 (69%) it
ecreased by 20%, which is considered an index of
ignificant positive reverse remodeling (20).
eterminants of remodeling. We observed a strong de-
endence of LV dilation upon the mass of dysfunctional but
iable myocardium. Patients having the largest amount of
Table 2. Echocardiographic Measurements
Interventricular septum diastole (cm)
Posterior wall diastole (cm)
LV internal diameter diastole (cm)
LV internal diameter systole (cm)
End-diastolic volume index (ml/m2)
End-systolic volume index (ml/m2)
LV sphericity index
Ejection fraction (%)
No. of dysfunctional segments/patient
Wall motion score index*
Meridional end-systolic wall stress ( 103 dyne/cm2
Circumferential end-systolic wall stress ( 103 dyne
Septal wall thickening (%)
Posterior wall thickening (%)
Data are mean  SD. p  statistical significance by paired
LV  left ventricular.igure 1. Individual changes in end-systolic volume index (ESVI), end-diastolic
fter revascularization. Bars  mean  SD.yssynergic myocardium at baseline were also those in
hom the largest decrease in ESVI and EDVI was observed
fter revascularization (Figs. 2A and 2B). Furthermore,
igure 2C shows a direct relationship when changes in
SVI or EDVI are plotted as a function of the number of
yocardial segments that recovered contractility at follow-
p. Interestingly, our data indicate that the relationship
etween severity of contractile deficit and LV dilation is
ctually maintained also in the post-revascularization con-
ition. Figure 3 shows the significant correlation between
MSI and absolute values of ESVI at baseline (left panel).
hen the plot was repeated, analyzing follow-up data (right
anel), although there was an expected improvement in
egional function and volumes as a consequence of revascu-
arization, ESVI continued to be linearly correlated to
MSI. This observation suggests that degree of contractile
unction influences systolic volumes, regardless of revascu-
arization status. Together, these various findings demon-
trate that the greater the degree of dysfunction, the greater
he impact on LV remodeling.
Among patients studied, seven (17%) actually had no or
egligible evidence of myocardial viability by dobutamine
Baseline Follow-Up p Value
1.00  0.20 1.02  0.19 ns
0.89  0.18 0.92  0.13 ns
6.61  0.55 6.12  0.65 0.0001
5.35  0.76 4.65  0.85 0.0001
118  26 99  26 0.0001
78  23 56  23 0.0001
0.69  0.14 0.52  11 0.0001
33  6 45  10 0.0001
12  3 7  4 0.0001
2.29  0.31 1.74  0.42 0.0001
158  55 107  40 0.0001
314  95 227  75 0.0001
23  20 33  23 0.01
43  23 49  21 0.069
nd *Wilcoxon rank sum test.)
/cm2)volume index (EDVI), and sphericity index (SI) from baseline to follow-up
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March 7, 2006:969–77 Hibernation and Remodelinghallenge at baseline. They still underwent revascularization
n the basis of clinical considerations made by attending
hysicians and predictably showed no appreciable recovery
f regional function after revascularization (0.9 1 segment
er patient). We retrospectively reanalyzed data from these
atients separately, as they afford the opportunity to evaluate
hether LV dilation might improve at follow-up indepen-
ently of recovery of function, but because of other possible
ffects of revascularization. Baseline characteristics of pa-
ients according to the response to dobutamine are shown in
able 3. At baseline, patients with and without viability had
ery similar values of global and regional function and of LV
olumes. At follow-up, ESVI decreased in 29 of 35 patients
igure 2. Correlations between echocardiographic indices of viability and
ollow-up. (Upper panels) (A) DeltaESVI 5.576 (5.472 no. of via
(62.13  viability index); SEE  6.9; (C) DeltaESVI  0.9636 
eltaEDVI  4.3256  (3.3366  no. of viable segments); SEE  5.6
eltaEDVI  0.2879  (2.9370  no. of recovered segments); SEE igure 3. Correlations between absolute values of end-systolic volume index (E
0.05) and at follow-up (right; r  0.66, p  0.0001).83%) in whom viability was present, whereas ESVI did
ot change or even increased in all patients without viable
yocardium (Table 4). Similarly, NYHA functional
tatus significantly improved at follow-up in patients with
yocardial viability (p  0.0001), whereas it remained
nchanged in patients without myocardial viability (Ta-
le 3). Figure 4 shows changes in ESVI, EDVI, and SI,
rought about by revascularization when data are ana-
yzed according to the initial response to dobutamine. A
triking difference is present, because viability at baseline
redicted marked and directionally opposite changes in
V volumes at follow-up. Two illustrative cases are
hown in Figure 5.
ges in ESVI (upper panels) or EDVI (bottom panels), from baseline to
gments); standard error of estimate (SEE) 6.6; (B) DeltaESVI 3.601
.183  no. of recovered segments); SEE  4.3. (Bottom panels) (A)
DeltaEDVI  4.9007  (41.6070  viability index); SEE  5.61; (C)
. Abbreviations as in Figure 1.chan
ble se
(5SVI) and wall motion score index (WMSI), at baseline (left; r  0.39, p
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Hibernation and Remodeling March 7, 2006:969–77To further characterize the independent contribution of
eversible dysfunction to remodeling, multiple regression
nalysis was performed. Variables used were: age, diabetes,
ypertension, hypercholesterolemia, previous myocardial
nfarction, medication, baseline ejection fraction, type of
evascularization (coronary artery by-pass graft vs. percuta-
eous transluminal coronary angioplasty), number of ste-
osed vessels, baseline EDVI and ESVI, VI, and number of
egments recovering function after revascularization. For
ultiple regression analysis, factors showing a value of p 
.1 in univariate analysis were selected. Number of segments
ith recovery of function after revascularization (p 
.0001) and VI (p  0.01) were the only independent
redictors of a change in ESVI 20% at follow-up.
able 3. Clinical Characteristics of Patients Divided According
o Presence or Absence of Viable Myocardium by Low-Dose
obutamine Echocardiography
Viability 
(n  35)
Viability 
(n  7)
ge (yrs) 65  9 67  9
ales (%) 29 (83) 6 (86)
SA (m2) 1.87  0.18 1.90  0.14
ystolic blood pressure (mm Hg) 129  15 121  10
iastolic blood pressure (mm Hg) 79  10 72  7
eart rate (beats/min) 72  12 70  15
YHA functional class baseline 3.0  0.8 3.6  0.8
YHA functional class follow-up 1.5  0.7* 3.1  0.7
oronary anatomy (%)
1-vessel disease 5 (14) 1 (14)
2-vessel disease 11 (31) 1 (14)
3-vessel disease 19 (54) 5 (71)
Revascularization
PTCA 10 (29) 2 (29)
CABG 25 (71) 5 (71)
p  0.0001 vs baseline by unpaired t test for continuous variables, or contingency
ables.
BSA  body surface area; NYHA  New York Heart Association.
Table 4. Echocardiographic Parameters at Bas
Patients Divided According to Presence of Via
Viabi
Baselin
Interventricular septum diastole (cm) 1.00  0.
Posterior wall diastole (cm) 0.88  0.
LV internal diameter diastole (cm) 6.55  0.
LV internal diameter systole (cm) 5.26  0.
Septal wall thickening (%) 23  19
Posterior wall thickening (%) 42  24
End-diastolic volume index (ml/m2) 118  24
End-systolic volume index (ml/m2) 77  23
LV sphericity index 0.70  0.
Ejection fraction (%) 34  6
No. of dysfunctional segments/patient 12  3
Wall motion score index 2.27  0.
No. of viable segments/patient 7  2
Viability index 0.56  0.
No. of recovered segments/patient na
*p  0.0001 vs. baseline; †p  0.05 vs. baseline; ‡p  0.01 v
repeated measures corrected for unbalanced design).
LV  left ventricular.ISCUSSION
he present study shows that in patients with coronary
rtery disease, presence of a substantial amount of dysfunc-
ional but otherwise viable myocardium is associated with
ajor alterations of LV volumes and shape. Those alter-
tions largely reverted when contractility of dyssynergic
reas was restored by revascularization. Together, these data
emonstrate that impairment of contractile function per se
ight play a major role for development of ischemic LV
emodeling and that extensive scar formation is not an
bligatory prerequisite in this process.
Because of the relevance of the phenomenon, under-
tanding the mechanisms through which ischemic re-
odeling occurs has spurred much interest. This has
esulted in many experimental studies, which have mostly
ocused, however, on processes involved with local repar-
tive changes, the emphasis being on biochemical and
ellular aspects of the healing process, such as changes in
ollagen metabolism (7,8) and inflammation (6,9,21)
also see the Appendix). Yet, occurrence of necrosis
mplies more than a series of inflammatory/reparatory
vents, however important, because loss of contractile
unction is the first and foremost consequence of myo-
ardial infarction. This issue is particularly relevant,
ecause impaired function of the infarcted area increases
V wall stress and stretching of remote myocardium,
actors potentially capable of triggering remodeling
7,10,22). In spite of this, information about a specific
ole of contractile dysfunction in remodeling is scarce;
his conceivably comes from the difficulty in separating
he effects of dyssynergy from those of necrosis. The only
lue comes from a swine model of chronic (two months)
oronary stenosis (23) in which persistent coronary flow
and at Follow-Up After Revascularization in
at Entry
(n  35) Viability  (n  7)
Follow-Up Baseline Follow-Up
1.03  0.18 0.98  0.27 0.96  0.0.25
0.93  0.11 0.93  0.26 0.85  0.19
5.97  0.55* 6.88  0.60 6.89  0.60
4.41  0.67* 5.79  0.86 5.85  0.66
35  21† 21  27 22  29
49  22 46  19 49  13
93  21* 121  37 132  27‡
50  16* 84  29 91  21*
0.51  0.11* 0.61  0.11 0.59  0.10
47  9* 31  6 31  6*
6  4 12  3 11  3‡
1.63  0.38* 2.38  0.34 2.24  0.25‡
na 2  1§
na 0.12  0.09§
6  3 0.9  1§
ility ; §p  0.0001 vs. viability  (analysis of variance foreline
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March 7, 2006:969–77 Hibernation and Remodelingeduction was associated with regional dysfunction but no
nfarct; these changes were accompanied by LV remod-
ling with increased cavity size and mass (23).
Rahimtoola (24) was the first to attract attention to the
eculiar condition in which areas of LV are non-contracting
et retain viability. He also suggested that revascularizing
hese hearts would improve LV function and volumes. This
linical condition has been popularized as myocardial “hi-
ernation.” Actually, it is becoming progressively evident
hat, in addition to true hibernation, the pathophysiology of
hronically dysfunctional yet viable myocardium might be
ore complex, encompassing also “repetitive stunning” and
assive tethering (25,26). These entities might be difficult to
istinguish clinically and might even coexist (25,27–30);
owever, regardless of the precise initiating mechanism,
hey are all characterized by presence of dyssynergic but
iable myocardium, which is amenable to recovery upon
evascularization. In the present study we took advantage of
his condition, as it offers two distinct advantages: first, it
llows direct investigation of the effects of regional dyssyn-
rgy on LV geometry and shape in the absence of changes
econdary to the healing process; second, since this “dor-
ant” myocardium might recover its function after revas-
ularization, it offers the opportunity to “double-check” the
ypothesis that impaired contractility might contribute to
emodeling, by investigating whether recovery of function
lso results in reversal of LV remodeling.
Several lines of evidence concur to indicate that in our
atients LV remodeling was directly linked to the presence of
arge areas of hibernating myocardium. First, we made efforts
o select patients without transmural scars; although it is
ossible that additional investigation (e.g., by magnetic reso-
ance imaging) could have revealed focal areas of necrosis, the
ombination of electrocardiogram and echocardiography crite-
ia, the absence of visible scar at surgery, and the presence of
notropic reserve indicate that extensive necrosis was unlikely.
econd, regional function did improve after revascularization:
mportantly, this was accompanied by reversal of LV remod-
ling, the extent of which was strictly related to the extent of
igure 4. Percent changes in left ventricular volumes and geometry at follow-u
obutamine echocardiography before revascularization. EDVI  end-diastoliunctional recovery (Figs. 2 and 3), indicating that the larger ehe dyssynergic area, the greater the impact on LV geometry
nd volumes, which might nonetheless revert upon restoration
f contractility. Finally, in patients with altered LV volumes
nd geometry—in whom, however, no viability was
resent—revascularization did not improve regional func-
ion (Figs. 4 and 5, Table 4). Consistent with our hypoth-
sis, these patients showed no reversal of remodeling at
ollow-up; this finding also rules out other effects of revas-
ularization as an explanation for our observations. To-
ether, these data demonstrate that regional dysfunction per
e might play a direct role in ischemic LV remodeling in
atients.
The mechanisms by which regional dyssynergy might in-
uce and maintain LV remodeling can only be postulated.
evere LV dysfunction with reduced cardiac output stimulates
ompensatory mechanisms that might promote remodeling,
uch as adrenergic and renin-angiotensin system activation
7,22). Furthermore, increased LV radial length might increase
egional wall stress (Table 2), which in turn induces an increase
n oxygen consumption of inner subendocardial layers. Because
ibernating myocardium is characterized by reduced coronary
ow reserve, an increase in oxygen demand might induce
schemia (27–29). We (31) and others (32) have shown in
atients that transient episodes of increased oxygen demand
ight induce prolonged contractile impairment (i.e., “stun-
ing”), which might be cumulative (32). Evidence is accumu-
ating to indicate that there might be a temporal progression
rom repetitive episodes of ischemia-reperfusion to hibernation
25,27–29,33), whereas viability might be maintained because
ibernating myocardium is relatively tolerant toward ischemia
28,33,34). This sequence might be interrupted upon revascu-
arization, which might reverse ischemia (if resting blood flow
s low) and/or prevent repetitive stunning. Interestingly, even
n the absence of extensive necrosis, there might still be a role
or inflammation in the pathophysiology of remodeling. Hi-
ernating myocardium shows signs of chronic inflammation,
kin to what is found after experimental microembolization
27,35). Furthermore, if “loss of contractile units” (due to
ecrosis) is actually the initial trigger of an array of molecular
ording to presence of viability (Viab) or absence of viability (Viab) during
me index; ESVI  end-systolic volume index; SI  sphericity index.p accvents leading to remodeling at the cellular level (36), then it
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Hibernation and Remodeling March 7, 2006:969–77ight be speculated that a “functional loss” of contractile units
ight similarly occur in the presence of large areas of hiber-
ating myocardium.
tudy limitations. In our series, typical of investigations on
atients with hibernation, the precise condition of the LV
efore initiating the whole process is unknown; however,
ecovery after revascularization is an indication of the revers-
bility of the phenomenon and hence a clue to the initial status.
nother limitation lies with patient population; on the one
and, we cannot rule out a role for subendocardial necrosis,
ecause no specific magnetic resonance imaging assessment
as performed. On the other hand, by study design we
xcluded patients with clear evidence of transmural scar: thus,
ur data might not be applicable to patients with chronic
igure 5. Two-dimensional apical four-chamber view of left ventricular (
onths after revascularization (right). (A) In a patient with no viable m
emodeling at follow-up. (B) In a patient with substantial myocardial viab
evascularization. Marked reduction of LV end-diastolic and end-systolicardiomyopathy secondary to large transmural infarction. Fi- tally, because of the lack of regional myocardial blood flow
easurements, we cannot establish the role of repeated stun-
ing as the main mechanism of dyssynergy.
mplications. The finding that dyssynergy , in itself, might
romote remodeling might have potentially important impli-
ations. First, because of expanding use of reperfusion therapy,
ess frequently do patients with acute myocardial infarction
evelop large areas of transmural necrosis; yet, our data suggest
hat they might not be spared from remodeling if myocardium
alvaged from necrosis remains dysfunctional. Second, recog-
ition that a sizable portion of LV is actually hibernating in
any patients with ischemic cardiomyopathy (37,38) suggests
hat LV function and size might improve in these patients as
n effect of revascularization. Finally, if what matters is con-
nd-diastolic and end-systolic cavity silhouettes at baseline (left) and 4
rdium (viability index  0.13), no recovery of function and no reverse
(viability index  0.56) and eight segments that recovered function after
es is appreciable at follow-up examination.LV) e
yoca
ilityractile reserve, regardless of the specific pathophysiology
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March 7, 2006:969–77 Hibernation and Remodelingnderlying dyssynergy, our data suggest that dobutamine echo
ight be the preferred test to predict reversal of remodeling.
In conclusion, our data show that, in patients with chronic
schemic heart disease, the alterations of LV volumes and
eometry, which are a hallmark of post-infarction remodeling,
an be directly induced by impaired function of hibernating
yocardium.
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PPENDIX
or a list of publications linking left ventricular remodeling
o inflammation/scar formation after transmural necrosis
nd the baseline clinical characteristics of individual pa-
ients, please see the online version of this article.
